Study S002569

A Prospective Decision Impact Trial of KidneyIntelX in Patients With Type 2 Diabetes and Existing Chronic Kidney Disease

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT04791358
Study type: OBSERVATIONAL
Status: ACTIVE_NOT_RECRUITING
Enrollment: 1500
Start: 2021-11-01
Primary completion: 2026-11-01
Lead sponsor: Renalytix AI, Inc.
Conditions: Diabetic Kidney Disease
Interventions: DIAGNOSTIC_TEST:KidneyIntelX
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Blood pressure [12 Months]
HbA1c [12 Months]
ACEi/ARB [12 Months]
SGLT2/ GLP1 [12 Months]
Urine albumin to creatinine ratio [12 Months]
Referrals [12 Months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.